Abstract:BackgroundThe gut microbiota plays an important role in human health and disease by acting as a metabolic organ. Metagenomic sequencing has shown how dysbiosis in the gut microbiota is associated with human metabolic diseases such as obesity and diabetes. Modeling may assist to gain insight into the metabolic implication of an altered microbiota. Fast and accurate reconstruction of metabolic models for members of the gut microbiota, as well as methods to simulate a community of microorganisms, are therefore needed. The Integrated Microbial Genomes (IMG) database contains functional annotation for nearly 4,650 bacterial genomes. This tremendous new genomic information adds new opportunities for systems biology to reconstruct accurate genome scale metabolic models (GEMs).ResultsHere we assembled a reaction data set containing 2,340 reactions obtained from existing genome-scale metabolic models, where each reaction is assigned with KEGG Orthology. The reaction data set was then used to reconstruct two genome scale metabolic models for gut microorganisms available in the IMG database Bifidobacterium adolescentis L2-32, which produces acetate during fermentation, and Faecalibacterium prausnitzii A2-165, which consumes acetate and produces butyrate. F. prausnitzii is less abundant in patients with Crohn’s disease and has been suggested to play an anti-inflammatory role in the gut ecosystem. The B. adolescentis model, iBif452, comprises 699 reactions and 611 unique metabolites. The F. prausnitzii model, iFap484, comprises 713 reactions and 621 unique metabolites. Each model was validated with in vivo data. We used OptCom and Flux Balance Analysis to simulate how both organisms interact.ConclusionsThe consortium of iBif452 and iFap484 was applied to predict F. prausnitzii’s demand for acetate and production of butyrate which plays an essential role in colonic homeostasis and cancer prevention. The assembled reaction set is a useful tool to generate bacterial draft models from KEGG Orthology.

Expression-Based Inference of Human Microbiome Metabolic Flux Patterns in Health and Disease

Proteome allocation of the microbiome reveals how diet and metabolic dysbiosis impact disease

Expression-Based Inference of Cancer Metabolic Flux Differences

Integration of multiview microbiome data for deciphering microbiome-metabolome-disease pathways

Strain-level Dissection of the Contribution of the Gut Microbiome to Human Metabolic Disease

Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease

The Human Microbiota in Health and Disease

The metabolomic physics of complex diseases

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders

Interplay between the human gut microbiome and host metabolism

FROM MICROBIOME TO METABOLOME

Symbiotic gut microbes modulate human metabolic phenotypes

Global Compositional and Functional States of the Human Gut Microbiome in Health and Disease

Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome

A core microbiome signature as an indicator of health

Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction

Adapting functional genomic tools to metagenomic analyses: investigating the role of gut bacteria in relation to obesity.

Host-microbiome protein-protein interactions reveal mechanisms in human disease

Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors

Combing fecal microbial community data to identify consistent obesity-specific microbial signatures and shared metabolic pathways

Mechanistic Links Between Gut Microbial Community Dynamics, Microbial Functions and Metabolic Health